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Resumo
A Doença relacionada à IgG4 é uma entidade 
recentemente reconhecida que inclui um grupo 
de doenças fibroinflamatórias auto-imunes que 
apresentam características histologicas típicas. 
Pode afectar múltiplos órgãos, produzindo um 
amplo espectro de apresentações clínicas.A 
seleção dos métodos de imagem adequados é 
baseada nos sintomas do doente e no órgão em 
avaliação.O diagnóstico baseia-se na integração 
de achados radiológicos e histopatológicos, 
elevação da IgG4 sérica, associação com 
outras doenças IgG4 e resposta a corticoides. 
Descrevemos um caso raro de mesenterite 
esclerosante relacionada à IgG4 num homem 
que se apresentou com uma massa mesentérica 
incidental no quadrante inferior direito e que 
teve insucesso terapêutico com corticoides. 
O envolvimento isolado do mesentério é 
uma forma rara de apresentação da doença 
relacionada à IgG4, estando apenas poucos 
casos descritos na literatura.
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Abstract
IgG4 related disease (IgG4 RD) is a newly 
recognized entity that includes a group 
of  immune-mediated fibro-inflammatory 
conditions. It can affect a wide range of  organs, 
producing a broad spectrum of  presentations. 
The selection of  imaging modality is based 
on patient symptoms and the organs under 
evaluation. The diagnosis is based on a 
combination of  radiological findings, serum 
IgG4 elevation levels, histopathological 
features, association with other IgG4-related 
diseases and response to steroids.
We report a rare case of  an IgG4-related 
sclerosing mesenteritis in a man who presented 
with an incidental right lower quadrant 
mesenteric mass and was unsuccessfully treated 
with corticoids. Isolated mesentery involvement 
is a rare presentation of  IgG4-related disease 
and only few cases were reported in literature.
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Radiological Case Report / Caso Clínico
Introduction
IgG4-related disease (IgG4-RD) represents a heterogeneous 
group of  immune-mediated fibro-inflammatory conditions 
that can affect multiple organs, leading to tumefactive, tissue-
destructive lesions, and organ failure.1,2 The epidemiology of  
this rare disease remains poorly described, but it seems to 
have a predilection for middle-aged to elderly males.3
The disease most commonly implicates the pancreas, but it can 
also involve the biliary tract, salivary glands, lacrimal glands, 
retroperitoneum or lymph nodes.4 Clinical presentation is 
typically subacute with varied and unspecific manifestations, 
depending on the affected organs and the mass effect exerted 
by the lesions on the viscera and vessels.5 Some cases remain 
asymptomatic and are detected incidentally.6
The selection of  an imaging modality should be based on 
symptoms and the organs under evaluation.1 Elevated serum 
IgG4 concentration is often, but not always present, so 
it is unreliable as diagnostic marker.3 However, it remains 
important for patient assessment as it seems to correlate with 
the number of  organs involved.1 Tissue biopsy for diagnostic 
confirmation and exclusion of  malignancies is strongly 
recommended and clinicopathologic correlation is essential.3
Multiple treatment approaches have been suggested, 
including “watchful waiting” in asymptomatic patients, 
use of  systemic corticoids, and surgical debulking.1 In 
refractory cases, “steroid-sparing” immunosuppressive 
drugs or biologic agents may be used.
Case Report
A 60-year-old man was admitted to our hospital to study 
an incidental right mesenteric mass found during a 
routine pelvic ultrasound. The patient was asymptomatic 
and had no relevant surgical or medical history. His 
physical examination and laboratory workup were 
normal. Computed tomography (CT) revealed a 8-cm, 
lobulated, well-circumscribed, soft tissue mass, located at 
the mesentery fat of  the right lower quadrant, anterior 
to the right psoas muscle and external iliac vessels, 
with surrounding fatty straining. The mass pushed 
the right ureter without causing upstream dilatation. 
No lymphadenopathy, vascular encasement or signs 
of  local invasiveness were present (Figure 1). Further 
magnetic resonance imaging (MRI) was performed. 
The lesion showed hypersignal in T2-weighted images 
(T2WI), hyposignal in T1-weighted images (T1WI), 
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and slight enhancement after gadolinium-based contrast 
administration (Figure 2).
Percutaneous biopsy revealed a fibrosing lesion with 
storiform pattern, focal areas of  lymphoplasmocitary 
infiltration and high number of  IgG4-positive plasmocytes 
(more than 40% and more than 30 cells/HPF). Obliterative 
vasculitis lesions were also observed, with no evidence of  
neoplasic or granulomatous tissue. The histological findings 
were compatible with IgG4-RD.
Post-biopsy serum IgG4 levels were within the normal 
range, and the remaining laboratory research was 
unremarkable.
The final diagnosis was IgG4-related mass-like sclerosing 
mesenteritis. The patient was discharged with scheduled 
follow-up and underwent no treatment, as he was 
asymptomatic. A year later, the patient remained free of  
symptoms, but the mass showed continuous growth on 
follow-up CT, so 40mg/day prednisolone was started. The 
mass kept growing under steroid therapy and methotrexathe 
15mg/6months was introduced. Four years of  follow-up 
documented clinical and radiological stability.
Although the current gold standard for the diagnosis of  
IgG4-RD is histological assessment, it also depends on the 
combination of  other features like radiological findings, 
elevated serum IgG4 levels, association with other IgG4-
related diseases, and response to steroids (Table 1).3 It 
remains a challenging diagnosis due to the broad spectrum 
of  affected organs and lack of  universal criteria including 
all patients with IgG4-RD.11,12 Established diagnostic 
criteria were proposed for the most common involved 
organs (pancreas, biliary tree, kidney and salivary/lachrymal 
glands), but are not yet established for the remaining sites. 
11,12 Appropriate histopathological findings are essential for 
diagnosis plus at least one additional criterion (serology, 
steroid responsiveness or other organ involvement).11
Figure 1 – Axial and coronal contrast enhanced-CT showing the mass 
(yellow arrow). The green arrow shows the right ureter, without upstream 
dilatation.
Figure 2 – MRI with axial T1-WI and T2-WI. Yellow arrows show the 
mass, which has isointensity to muscle in T1-WI and hypersignal in T2-
WI.
Discussion
Isolated mass-like sclerosing mesenteritis (SM) is a rare 
form of  presentation of  IgG4-RD, with only few cases 
described in literature. Most frequently, retroperitoneal or 
diffuse mesenteric root involvement are observed.7
Both IgG4-RD and SM show male predominance, in 
middle-aged to elderly man, and have unclear etiology, as in 
the case described.8,9,10
The course of  IgG4-RD is uncertain. A few cases improve 
spontaneously, and most show subacute or chronic 
progression. The severity of  symptoms depends on the 
disease activity and the pattern of  organ involvement.11 
Constitutional symptoms and fever are unusual.2 In the 
particular case of  SM, chronic abdominal pain is the 
most common presentation, often associated with nausea, 
vomiting, cramping or diarrhea.6,9 However, patients may 
be asymptomatic and diagnosed incidentally through 
radiologic findings, as in our case, or in pathological 
specimens.
Table 1 – Adapted from Current Topics in Microbiology and Immunology, 
201611
The major histological findings include abundant infiltration 
of  IgG4-positive plasma cells and lymphocytes, storiform 
fibrosis, and obliterative phlebitis.11 Persistent inflammation 
has been shown to lead to swelling and fibrosis, leading 
to organ dysfunction. The diagnosis may be difficult in 
chronic lesions that have become predominantly fibrotic.
A majority of  patients with IgG4-RD have high serum 
IgG4 levels, but approximately 30% of  patients have 
values within normal range, mostly patients with early or 
limited disease.3 Elevated serum IgG4 levels may also be 
seen in autoimmune or allergic conditions, carcinomas and 
Castleman´s disease.11 Despite not being sensitive neither 
specific, the degree of  serum IgG4 elevation correlates 
with the number of  organs involved.1
IgG4-RD’s imaging findings are nonspecific.2,5 Contrast-
enhanced-CT images may show diffuse or focal swelling 
of  organs or soft tissue masses, usually with well-defined 
margins and homogeneous delayed phase enhancement. 
Isointensity to muscle on T1-weighted MRI and 
hypointensity on T2-weighted MRI reflect fibrosis, while 
high T2 signal may be seen in active phases of  disease, 
representing inflammatory edema.10 Fluorodeoxyglucose 
positron emission tomography-computed tomography 
(FDG-PET/CT)) can be useful for assessing IgG4-RD 
involvement in other organs by highlighting hypermetabolic 
activity.11
Mesenteric involvement in IgG4-RD is more common in 
the small bowel mesentery.5 However, in our patient, single 
involvement of  the mesocolon was seen, which has been 
described in 20% of  cases.9 In general, it can present as 
diffuse thickening of  the root of  mesentery, or as single 
or multiple masses. Some signs were described, including 
the “fat-ring” sign (area of  preserved fat around the 
mesenteric vessels) and a “tumoral pseudocapsule” (band 
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of  soft tissue surrounding the inflammed mass).5,9 Misty 
mesentery sign is a nonspecific feature and refers to diffuse 
increased attenuation in the mesentery often associated 
with small to borderline-sized nodes, representing chronic 
inflammation. Calcification and fat necrosis may also 
be seen.10 With disease progression, fibrosis becomes 
prominent and retractile changes may encase vessels and 
compress abdominopelvic organs.10
Based only on imaging findings, our differential diagnoses 
had to include both neoplastic and inflammatory diseases, 
such as sarcoma, inflammatory malignant fibrous 
histiocytoma, lymphoma, desmoid tumor, inflammatory 
pseudotumor, and mass-like sclerosing mesenteritis, so 
percutaneous biopsy and consequent histological analysis 
were critical for the final diagnosis.6,7
No generalized consensus regarding the treatment of  
SM in IgG4-RD exists, so it is customized for each 
patient.6,8 Asymptomatic patients may delay treatment 
and be kept in “watchful waiting”. However, fewer long-
term complications and higher rates of  remission were 
reported on patients that received prompt treatment.1 
For symptomatic patients, prednisone is recommended 
to induce remission and continued for up to 3 years 
at reduced doses (2,5mg or 5mg/day).3 Alternative 
treatments in refractory disease or steroid intolerance 
have been proposed, including immunomodulatory drugs 
(azathioprine, methotrexathe) or rituximab.2,11 IgG4-related 
disease generally responds well to glucocorticoids during its 
inflammatory stage, but in chronic, highly fibrotic lesions, 
recurrent or refractory cases are common.1,2 Surgical 
resection or debulking may have a role in symptomatic 
relief, but does not prevent disease progression.6
In summary, we present a case of  focal mass-like SM, 
representing a rare manifestation of  an IgG4-RD. Due 
to its rarity, wide range of  organs affected and confusing 
nomenclature in literature, more cases and studies are 
needed to characterize the IgG4-RD spectrum and raise 
awareness about this condition.
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